Targeting BRCAness in Gastric Cancer
Technical Report,15 Sep 2017,14 Sep 2018
Memorial Sloan Kettering Cancer Center New York United States
Pagination or Media Count:
In the past year, we have made substantial progress in the projects goals. We have set up a system described below to interrogate gastric cancer cells with ATR and PARP inhibitors. This screening platform is now up and running and we are prosecuting preliminary hits. Over the next year, we will validate hits generated here and further the interrogation of clinical samples.
- Medicine and Medical Research
- Genetic Engineering and Molecular Biology